HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional)

Federal funding opportunity RFA-DA-25-062 from National Institutes of Health (Department of Health and Human Services).

Program funding history

Synopsis

Who can apply

• Special district governments
• Native American tribal organizations (other than Federally recognized tribal governments)
• State governments
• Native American tribal governments (Federally recognized)
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• Small businesses
• County governments
• Independent school districts
• Public housing authorities/Indian housing authorities
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• Private institutions of higher education
• For profit organizations other than small businesses
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• City or township governments
• Public and State controlled institutions of higher education

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

The official record

Similar grants

• HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)
  RFA-DA-28-011 · National Institutes of Health · closes January 26, 2027
• HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed)
  RFA-DA-28-012 · National Institutes of Health · closes January 26, 2027
• NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
  PA-27-100 · National Institutes of Health · closes April 5, 2027
• HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)
  RFA-DA-27-016 · National Institutes of Health · closes February 9, 2029
• HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
  RFA-NS-27-007 · National Institutes of Health · closes February 20, 2029
• Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2
  RFA-DA-28-001 · National Institutes of Health